Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively

por Moreno, Carol, Muñoz, Cecilia, Terol, María José, Hernández-Rivas, José-Ángel, Villanueva, Miguel
Publicado 2021

The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies

por Hernández-Rivas, José-Ángel, Ríos-Tamayo, Rafael, Encinas, Cristina, Alonso, Rafael, Lahuerta, Juan-José
Publicado 2022

Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up

por Dreyling, Martin, Goy, Andre, Hess, Georg, Kahl, Brad S., Hernández-Rivas, José-Ángel, Schuier, Natasha, Qi, Keqin, Deshpande, Sanjay, Zhu, Angeline, Parisi, Lori, Wang, Michael L.
Publicado 2022

The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment

por Pérez-Carretero, Claudia, González-Gascón-y-Marín, Isabel, Rodríguez-Vicente, Ana E., Quijada-Álamo, Miguel, Hernández-Rivas, José-Ángel, Hernández-Sánchez, María, Hernández-Rivas, Jesús María
Publicado 2021

The Five “Ws” of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When

por González-Gascón-y-Marín, Isabel, Ballesteros-Andrés, Mónica, Martínez-Flores, Sara, Rodríguez-Vicente, Ana-E, Pérez-Carretero, Claudia, Quijada-Álamo, Miguel, Rodríguez-Sánchez, Alberto, Hernández-Rivas, José-Ángel
Publicado 2023

From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct

por González-Gascón-y-Marín, Isabel, Muñoz-Novas, Carolina, Rodríguez-Vicente, Ana-Eugenia, Quijada-Álamo, Miguel, Hernández-Sánchez, María, Pérez-Carretero, Claudia, Ramos-Ascanio, Victoria, Hernández-Rivas, José-Ángel
Publicado 2021

Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study

por Loscertales, Javier, Abrisqueta-Costa, Pau, Gutierrez, Antonio, Hernández-Rivas, José Ángel, Andreu-Lapiedra, Rafael, Mora, Alba, Leiva-Farré, Carolina, López-Roda, María Dolores, Callejo-Mellén, Ángel, Álvarez-García, Esther, García-Marco, José Antonio
Publicado 2023

Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% o...

por Casado, Luis-Felipe, García-Gutiérrez, José-Valentín, Massagué, Isabel, Giraldo, Pilar, Pérez-Encinas, Manuel, de Paz, Raquel, Martínez-López, Joaquín, Bautista, Guiomar, Osorio, Santiago, Requena, María-José, Palomera, Luis, Peñarrubia, María-Jesús, Calle, Carmen, Hernández-Rivas, José-Ángel, Burgaleta, Carmen, Maestro, Begoña, García-Ormeña, Nuria, Steegmann, Juan-Luis
Publicado 2015

Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group

por Bailén, Rebeca, Kwon, Mi, Aguado, Beatriz, Duarte, Rafael F., Calbacho, Maria, Chinea, Anabelle, Llamas, Pilar, Riaza Grau, Rosalía, Hernandez-Rivas, Jose Angel, Jimenez Yuste, Victor, Martínez-Chamorro, Carmen, Penalver, F. Javier, González, Ataulfo, del Campo, Juan F, Quiroz, Keina, Oarbeascoa, Gillen, Garcia Suarez, Julio, Díez-Martín, José Luis
Publicado 2020

R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group

por Sancho, Juan‐Manuel, Fernández‐Alvarez, Rubén, Gual‐Capllonch, Francisco, González‐García, Esther, Grande, Carlos, Gutiérrez, Norma, Peñarrubia, María‐Jesús, Batlle‐López, Ana, González‐Barca, Eva, Guinea, José‐María, Gimeno, Eva, Peñalver, Francisco‐Javier, Fuertes, Miguel, Bastos, Mariana, Hernández‐Rivas, José‐Ángel, Moraleda, José‐María, García, Olga, Sorigué, Marc, Martin, Alejandro
Publicado 2021

Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study

por De Ramón, Cristina, Hernandez-Rivas, Jose Angel, Rodríguez García, Jose Antonio, Ocio, Enrique M., Gómez-Casares, María Teresa, López Jiménez, Javier, Solano, Carlos, Martínez-López, Joaquín, Sureda, Anna, Jurado, Manuel, Córdoba, Raul, Benavente, Celina, Marco, Pascual, Pérez-Simón, Jose Antonio, Moraleda, Jose Maria, Figuera, Angela, Pardal, Emilia, Pascual Izquierdo, Cristina, Garcia-Sanz, Ramon
Publicado 2020

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia

por Quijada‐Álamo, Miguel, Pérez‐Carretero, Claudia, Hernández‐Sánchez, María, Rodríguez‐Vicente, Ana‐Eugenia, Herrero, Ana‐Belén, Hernández‐Sánchez, Jesús‐María, Martín‐Izquierdo, Marta, Santos‐Mínguez, Sandra, del Rey, Mónica, González, Teresa, Rubio‐Martínez, Araceli, García de Coca, Alfonso, Dávila‐Valls, Julio, Hernández‐Rivas, José‐Ángel, Parker, Helen, Strefford, Jonathan C., Benito, Rocío, Ordóñez, José‐Luis, Hernández‐Rivas, Jesús‐María
Publicado 2021

Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression

por Quijada-Álamo, Miguel, Hernández-Sánchez, María, Rodríguez-Vicente, Ana-Eugenia, Pérez-Carretero, Claudia, Rodríguez-Sánchez, Alberto, Martín-Izquierdo, Marta, Alonso-Pérez, Verónica, García-Tuñón, Ignacio, Bastida, José María, Vidal-Manceñido, María Jesús, Galende, Josefina, Aguilar, Carlos, Queizán, José Antonio, González-Gascón y Marín, Isabel, Hernández-Rivas, José-Ángel, Benito, Rocío, Ordóñez, José Luis, Hernández-Rivas, Jesús-María
Publicado 2021

Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study

por Muñoz-Rivas, Nuria, Abad-Motos, Ane, Mestre-Gómez, Beatriz, Sierra-Hidalgo, Fernando, Cortina-Camarero, Cristina, Lorente-Ramos, Rosa María, Torres-Rubio, Pedro, Arranz-García, Paz, Franco-Moreno, Ana Isabel, Gómez-Mariscal, Eloy, Mauleón-Fernández, Cristina, Alonso-García, Soledad, Rogado, Jacobo, Saez-Vaquero, Teresa, Such-Diaz, Ana, Ryan, Pablo, Moya-Mateo, Eva, Martín-Navarro, Juan A., Hernández-Rivas, Jose Angel, Torres-Macho, Juan, Churruca, Juan
Publicado 2021

Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Contro...

por Muñoz-Rivas, Nuria, Aibar, Jesús, Gabara-Xancó, Cristina, Trueba-Vicente, Ángela, Urbelz-Pérez, Ana, Gómez-Del Olmo, Vicente, Demelo-Rodríguez, Pablo, Rivera-Gallego, Alberto, Bosch-Nicolau, Pau, Perez-Pinar, Montserrat, Rios-Prego, Mónica, Madridano-Cobo, Olga, Ramos-Alonso, Laura, Alonso-Carrillo, Jesús, Francisco-Albelsa, Iria, Martí-Saez, Edelmira, Maestre-Peiró, Ana, Méndez-Bailón, Manuel, Hernández-Rivas, José Ángel, Torres-Macho, Juan
Publicado 2022

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study

por Regalado-Artamendi, Isabel, Jiménez-Ubieto, Ana, Hernández-Rivas, José Ángel, Navarro, Belén, Núñez, Lucía, Alaez, Concha, Córdoba, Raúl, Peñalver, Francisco Javier, Cannata, Jimena, Estival, Pablo, Quiroz-Cervantes, Keina, Riaza Grau, Rosalía, Velasco, Alberto, Martos, Rafael, Domingo-González, Amalia, Benito-Parra, Laurentino, Gómez-Sanz, Elvira, López-Jiménez, Javier, Matilla, Arturo, Herraez, María Regina, Penalva, María José, García-Suárez, Julio, Díez-Martín, José Luis, Bastos-Oreiro, Mariana
Publicado 2021

IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice

por Sancho, Juan-Manuel, Marín-Niebla, Ana, Fernández, Silvia, Capote, Francisco-Javier, Cañigral, Carolina, Grande, Carlos, Donato, Eva, Zeberio, Izaskun, Puerta, Jose-Manuel, Rivas, Alfredo, Pérez-Ceballos, Elena, Vale, Ana, Martín García-Sancho, Alejandro, Salar, Antonio, González-Barca, Eva, Teruel, Anabel, Pastoriza, Carmen, Conde-Royo, Diego, Sánchez-García, Joaquín, Barrenetxea, Cristina, Arranz, Reyes, Hernández-Rivas, José-Ángel, Ramírez, María-José, Jiménez, Aroa, Rubio-Azpeitia, Eva
Publicado 2022

Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients

por Piñana, José Luis, Heras, Inmaculada, Aiello, Tommaso Francesco, García-Cadenas, Irene, Vazquez, Lourdes, Lopez-Jimenez, Javier, Chorão, Pedro, Aroca, Cristina, García-Vidal, Carolina, Arroyo, Ignacio, Soler-Espejo, Eva, López-Corral, Lucia, Avendaño-Pita, Alejandro, Arrufat, Anna, Garcia-Gutierrez, Valentín, Arellano, Elena, Hernández-Medina, Lorena, González-Santillana, Clara, Morell, Julia, Hernández-Rivas, José Ángel, Rodriguez-Galvez, Paula, Mico-Cerdá, Mireia, Guerreiro, Manuel, Campos, Diana, Navarro, David, Cedillo, Ángel, Martino, Rodrigo, Solano, Carlos
Publicado 2023

SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccin...

por Piñana, José Luis, Martino, Rodrigo, Vazquez, Lourdes, López-Corral, Lucia, Pérez, Ariadna, Chorão, Pedro, Avendaño-Pita, Alejandro, Pascual, María-Jesús, Sánchez-Salinas, Andrés, Sanz-Linares, Gabriela, Olave, María T., Arroyo, Ignacio, Tormo, Mar, Villalon, Lucia, Conesa-Garcia, Venancio, Gago, Beatriz, Terol, María-José, Villalba, Marta, Garcia-Gutierrez, Valentín, Cabero, Almudena, Hernández-Rivas, José Ángel, Ferrer, Elena, García-Cadenas, Irene, Teruel, Anabel, Navarro, David, Cedillo, Ángel, Sureda, Anna, Solano, Carlos
Publicado 2023

Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia

por Megías-Vericat, Juan Eduardo, Martínez-Cuadrón, David, López, Joaquín Martínez, Bergua, Juan Miguel, Tormo, Mar, Serrano, Josefina, González, Ataulfo, de Oteyza, Jaime Pérez, Vives, Susana, Vidriales, Belén, Herrera, Pilar, Vera, Juan Antonio, Martínez, Aurelio López, de la Fuente, Adolfo, Amador, Ma Lourdes, Hernández-Rivas, José-Ángel, Fernández, Ma Ángeles, Cerveró, Carlos Javier, Morillo, Daniel, Campo, Pilar Hernández, Gorrochategui, Julián, Primo, Daniel, Rojas, José Luis, Guenova, Margarita, Ballesteros, Joan, Sanz, Miguel, Montesinos, Pau
Publicado 2019